Exscientia plc EXAI 深 沪
已收盘 09-06 16:00:00 美东时间
4.90
+0.020
+0.41%
华盛通- 最 高4.93
- 今 开4.92
- 成交量 40.92万股
- 最 低 4.6801
- 昨 收 4.88
- 总市值 6.13亿
- 52周最高 7.91
- 市盈率 静 --
- 换手率 0.33%
- 52周最低 3.80
- 委 比 -92.98%
- 总股本 1.25亿
- 历史最高 30.38
- 量 比 0.50
- 振 幅 5.12%
- 历史最低 3.80
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Exscientia reports Q2 results
Exscientia press release (NASDAQ:EXAI): Q2 GAAP EPS of -$0.36. Revenue of $5.6M (+47.4% Y/Y). More on Exscientia Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others Exscientia...
08-16 13:57
Exscientia’s Strategic Merger and Pipeline Progress
Exscientia Plc (EXAI) has released an update. Exscientia Plc is set to revoluti...
08-15 19:47
Barclays Downgrades Exscientia to Equal-Weight, Announces $5 Price Target
Barclays analyst Peter Lawson downgrades Exscientia (NASDAQ:EXAI) from Overweight to Equal-Weight and announces $5 price target.
08-14 01:34
6.88亿美元！英伟达投资的AI新药公司拟收购其竞争对手
8月8日，利用人工智能发现新药的生物科技公司Recursion Pharmaceuticals (RXRX.O)已同意收购规模较小的竞争...
08-12 10:11
Exscientia Agrees to Acquisition by Recursion Pharmaceuticals
Exscientia Plc (EXAI) has released an update. Exscientia plc, an England and Wa...
08-09 05:50
TD Cowen downgrades Exscientia Plc (EXAI) to a Hold
Exscientia Plc (EXAI – Research Report) received a Hold rating and price target...
08-09 04:25
两家AI新药公司宣布合并，预计将实现1亿美元的协同效应
格隆汇8月8日｜Recursion和Exscientia plc今天宣布两家公司已达成最终协议，将Recursion和Exscientia合并。Recursi...
08-08 22:07
Exscientia(EXAI.US)获英伟达投资的Recursion(RXRX.US)收购 股价大涨16%
人工智能驱动的药物研发公司Recursion Pharmaceuticals(RXRX.US)已同意以6.88亿美元的价格全股票交易收购规模较小的竞争对手Exscientia(EXAI.US)
08-08 21:38
Nvidia-backed Recursion to acquire Exscientia in all-stock deal
Exscientia (NASDAQ:EXAI), an AI-driven drug discovery firm, has agreed to be acquired by its larger peer, Recursion Pharmaceuticals (NASDAQ:RXRX), whose backers include chipmaker Nvidia (NASDAQ:NVDA),...
08-08 19:54
